Biobehavioral outcomes following psychological interventions for cancer patients

Journal of Consulting and Clinical Psychology

Volumn 70, Issue 3, 2002, Pages 590-610

  Andersen, Barbara L ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PREDNISONE; VINCRISTINE;

ARTICLE; BEHAVIOR THERAPY; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; DIETARY INTAKE; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROBLEM SOLVING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SMOKING CESSATION; STRESS; TREATMENT OUTCOME;

EXERCISE; HEALTH BEHAVIOR; HUMANS; NEOPLASMS; SMOKING; STRESS, PSYCHOLOGICAL;

EID: 0036279085     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.70.3.590     Document Type: Article

References (199)

1. A problem-solving approach to stress reduction among younger women with breast cancer: A randomized controlled trial
2. A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients
3. Psychological interventions for cancer patients to enhance the quality of life
4. Surviving cancer
5. Stress and immune responses after surgical treatment for regional breast cancer
6. A biobehavioral model of cancer stress and disease course
7. Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: A controlled comparison
8. Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer
9. Sense of control and adjustment to breast cancer: The importance of control coping styles
10. Depression and tumor stage in cancer of the head and neck
11. Socio-economic factors and cancer incidence among Blacks and Whites
12. Screening depressed patients in family practice: A rapid technique
13. An inventory for measuring depression
14. Dose-response effect of adjuvant chemotherapy in breast cancer
15. Race, socioeconomic status, and breast cancer treatment and survival
16. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument
17. Natural killer cells and cancer
18. The Duke-UNC Functional Social Support Questionnaire: Measurement of social support in family medicine patients
19. Quality of life after adjuvant chemotherapy for breast cancer
20. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer
21. Antitumor and antimetastatic activity of interleukin 12 against murine tumors
22. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer
23. Development of a brief screening instrument for detecting depressive disorders
24. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer
25. The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure
26. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer
27. Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papilloma virus infection
28. Global measure of perceived stress
29. Measuring the functional components of social support
30. Symptoms of depression in two communities
31. Frequency and correlates of PTSD-like symptoms following treatment for breast cancer
32. Signaling antibodies in cancer therapy
33. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer
34. A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer
35. Effects of resistive exercise on skeletal muscle in marrow transplant recipients receiving total parenteral nutrition
36. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy
37. Phase II study of psychotherapeutic intervention in advanced cancer
38. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy
39. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy
40. The scientific and moral imperative for broad-based psychosocial interventions for cancer
41. Exercise
42. Patterns of coping with cancer
43. Development and preliminary evaluation of the Social Problem-Solving Inventory
44. A group cognitive behavior therapy programme with metastatic breast cancer patients
45. Description of a group cognitive behavior therapy programme with cancer patients
46. Effects of group CBT on the survival time of patients with metastatic breast cancer
47. Psychological response to long term group therapy: A randomized trial with women with metastatic breast cancer patients
48. Modulatory effects of glucocorticoid and catecholamines on human interleukin-12 and interleukin-10 production: Clinical implications
49. The effects of anxiety management training on psychological variables and immune parameters in cancer patients: A pilot study
50. The use of nicotine replacement therapy during hospitalization
51. Psychological adjustment in breast cancer: Processes of emotional distress
52. Depression in women treated for gynecological cancer: Clinical and neuroendocrine assessment
53. Stress responses and psychological adjustment in patients with cancer and their spouses
54. A structured psychiatric intervention for cancer patients: I. Changes over time in methods of coping and affective disturbance
55. Malignant melanoma: Effects of a structured psychiatric intervention, coping, affective state, and immune parameters on recurrence and survival six years later
56. A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures
57. Noradrenergic sympathetic innervation of the spleen: I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp
58. Assessing the important effector mechanisms in the immune response against cancer
59. A psychosocial group intervention for Japanese women with primary breast carcinoma
60. An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients
61. Breast cancer survivors: Psychosocial concerns and quality of life
62. Survival of breast cancer patients receiving adjunctive psychosocial support therapy: A 10 year follow-up study
63. Self-blame attributions in women with newly diagnosed breast cancer: A prospective study of psychological adjustment
64. The effect of group psychosocial support on survival in metastatic breast cancer
65. Quality of life in long-term survivors of adult-onset cancers
66. Trauma history as a predictor of psychologic symptoms in women with breast cancer
67. The effectiveness of a nurse-managed minimal smoking- cessation intervention among hospitalized patients with cancer
68. Predictors of long-term smoking cessation in head and neck cancer patients
69. Immunological responses of breast cancer patients to behavioral interventions
70. The role of gender and taste class in the effects of stress on eating
71. Marital satisfaction in patients with cancer: Does support from intimate partners benefit those who need it the most?
72. Cognitive-behavioral group therapy versus phenelzine in social phobia: 12 week outcome
73. Education and peer discussion group interventions and adjustment to breast cancer
74. Group support interventions for women with breast cancer: Who benefits from what?
75. Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer
76. Cancer prevalence and survivorship issues: Analyses of the 1992 National Health Interview Survey
77. Treatment failure and dietary habits in women with breast cancer
78. Impact of Event Scale: A measure of subjective stress
79. Symptom profile of nasopharyngeal cancer patients during radiation therapy
80. The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy
81. A randomized controlled trial of psychotherapeutic intervention in cancer patients
82. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: An 11-year follow-up study of a general population
83. Formation of food aversions in cancer patients receiving repeated infusions of chemotherapy
84. Depression and carcinoma of the pancreas
85. Reduction of natural killer cytotoxic activity in major depression: Interaction between depression and cigarette smoking
86. Comparison of two modes of stress measurement: Daily hassles and uplifts versus major life events
87. Effects of medical and psychotherapeutic treatment on the survival of women with metastatic breast carcinoma
88. Feasibility of using volunteer research staff to deliver and evaluate a low-fat dietary intervention: The American Cancer Society Breast Cancer Dietary Intervention Project
89. Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: Survival results of a trial
90. A presurgical psychosocial intervention for breast cancer patients: Psychological distress and the immune response
91. Personality, appraisal and cognitive coping processes, and performance during various conditions of stress
92. Relaxation training as an integral part of caring activities for cancer patients: Effects on well-being
93. Patient noncompliance with self-administered chemotherapy
94. Immune effects of relaxation during chemotherapy for ovarian cancer
95. Factors associated with acceptance or rejection of recommendation for chemotherapy in a community cancer center
96. Effects of counseling for late stage cancer patients
97. Psychosocial adaptation to cancer: The role of coping strategies
98. High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on quality of life jeopardize feasibility and acceptability of treatment?
99. Promoting the functional capacity of cancer patients
100. Effects of aerobic interval training on cancer patient's functional capacity
101. Catecholamine action and immunologic reactivity
102. Psychoneuroimmunology: The interface between behavior, brain, and immunity
103. Prognostic value of non-MHC-restricted killer cell activity in lung cancer
104. The impact of a psychological intervention on quality of life in non-metastatic breast cancer
105. Psychological distress after initial treatment of breast cancer
106. Psychological support for patients undergoing breast cancer surgery: A randomized study
107. Psychological impact of diagnosis and risk reduction among cancer survivors
108. Depression in patients with cancer: Diagnosis, biology, and treatment
109. Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck
110. Twelve-minute walking test for assessing disability in chronic bronchitis
111. Reducing distress in cancer patients with an orientation program
112. The persistent impact of breast carcinoma on functional health status: Prospective evidence form the Nurses' Health Study
113. Immune function in cigarette smokers who quit smoking for 31 days
114. Psychological interventions and the immune system: A meta-analytic review and critique
115. Pathways linking major depression and immunity in ambulatory female patients
116. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer
117. A comparison of adjuvant psychological therapy and supportive counselling in patients with cancer
118. Exercise and immune function: Recent developments
119. Dietary intervention in breast cancer patients: Effects on food choice
120. Feasibility of a randomized trial of a high-vegetable diet to prevent breast cancer recurrence
121. Health behavior changes after a cancer diagnosis: What do we know and where do we go from here?
122. Role of natural killer cells in cancer
123. Bidirectional interaction between the central nervous system and the immune system
124. Eysenck personality inventory L-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma
125. Behavioral intervention for cancer-treatment side-effects
126. Path model of multidimensional compliance with cancer therapy
127. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy
128. Psychosocial status at initiation of cancer treatment and survival
129. Coping, life attitudes, and immune responses to imagery and group support after breast cancer treatment
130. The identification of cancer antigens: Impact on the development of cancer vaccines
131. Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer
132. Psychiatric complications in cancer patients
133. Doctor-patient communication and outcome in cancer patients: An intervention
134. Prolactin synthesis and secretion by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation
135. Lyric effector cell activity and major depressive disorder in patients with breast cancer: A prospective study
136. Comorbidity and functional status in older women with breast cancer: Implications for screening, treatment, and prognosis
137. Association between subjective sleep quality and depression on immunocompetence in low-income women at risk for cervical cancer
138. Diet and risk for breast cancer recurrence and survival
139. Assessing problems of cancer patients: Psychometric properties of the cancer inventory of problem situations
140. Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation
141. Structural characteristics of social networks and their relationship with social support in the elderly: Who provides support?
142. Structured exercise improves physical functioning in women with stages I and II breast cancer: Results of a randomized controlled trial
143. Diurnal cortisol rhythm as a predictor of breast cancer survival
144. The effect of psychological interventions on anxiety and depression in cancer patients: Results of two metaanalyses
145. Effects of a psychosocial intervention on survival among patients with stage I breast and prostate Cancer: A matched case-control study
146. The exercise and immunity paradox: A neuroendocrine/cytokine hypothesis
147. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients
148. Mind matters: Group therapy and survival in breast cancer
149. Group therapy and hypnosis reduce metastatic breast carcinoma pain
150. Effect of psychosocial treatment on survival of patients with metastatic breast cancer
151. Group support for patients with metastatic cancer: A randomized outcome study
152. A smoking cessation intervention with hospitalized surgical cancer patients: A pilot study
153. Social comparison and adjustment to breast cancer: An experimental examination of upward affiliation and downward evaluation
154. The supportive care needs of men with prostate cancer (2000)
155. Head and neck cancer survival and lifestyle change
156. Diet and exercise regimens to improve breast carcinoma prognosis
157. Intensive outpatient adjuvant therapy for breast cancer: Results of dose escalation and quality of life
158. Preoperative psychological variables predict immunological status in patients with operable breast cancer
159. Social support and salivary cortisol in women with metastatic breast cancer
160. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: An exploratory study
161. Psychosocial stress moderates the relationship of cancer history with natural killer cell activity
162. Concomitant chemoradiotherapy as primary therapy for loco-regionally advanced head and neck cancer
163. Obesity
164. Review of recent developments in the molecular characterization of recombinant alfa interferons on the 40th anniversary of the discovery of interferon
165. Development and validation of brief measures of positive and negative affect: The PANAS scales
166. Development of a questionnaire measure of adjustment to cancer: The MAC scale
167. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
168. A nurse-delivered smoking cessation intervention among hospitalized postoperative patients-influence, of a smoking-related diagnosis: A pilot study
169. The role of natural killer cells in human disease
170. Goals for nutrition in the year 2000
171. Effect of aerobic exercise on patient reports of nausea
172. Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy
173. Exercise and cellular innate immune function
174. Defective natural killer activity in gastric cancer patients: Possible involvement of suppressor factor receptor
175. Higher natural killer activity in schizophrenic patients: The impact of serum factors, medication, and smoking
176. Breast cancer surgery: Comparing surgical groups and determining individual differences in postoperative sexuality and body change stress
177. Nutrition in head and neck cancer
178. Better breast-cancer survival for postmenopausal women who are less overweight and eat less fat-The Iowa Women's Health Study
179. The Hospital Anxiety and Depression scale
180. The relationship of depression and stressors to immunological assays: A meta-analytic review